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Summ a r y
Mucocutaneous fungal infections are typically found in patients who have no known 
immune defects. We describe a family in which four women who were affected by 
either recurrent vulvovaginal candidiasis or onychomycosis had the early-stop-codon 
mutation Tyr238X in the β-glucan receptor dectin-1. The mutated form of dectin-1 
was poorly expressed, did not mediate β-glucan binding, and led to defective pro-
duction of cytokines (interleukin-17, tumor necrosis factor, and interleukin-6) after 
stimulation with β-glucan or Candida albicans. In contrast, fungal phagocytosis and 
fungal killing were normal in the patients, explaining why dectin-1 deficiency was 
not associated with invasive fungal infections and highlighting the specific role of 
dectin-1 in human mucosal antifungal defense.
Recurrent vulvovaginal candidiasis is a relatively common pathological condition, afflicting women of all ages, with more than 90% of cases caused by C. albicans.1 Although the role of diabetes as a predisposing 
condition has been recognized, most cases occur in healthy women. Recurrent oral, 
esophageal, or mucocutaneous candidiasis is also diagnosed in some patients with-
out clear predisposing factors. Onychomycosis is a common infection of the nail 
beds, most often caused by dermatophytes but sometimes caused by C. albicans, that 
also affects immunocompetent persons.2 In contrast, disseminated forms of can-
dida infections are mostly found in patients in whom a defect in neutrophil func-
tion is easily recognized or candida species have been introduced in the blood-
stream through invasive procedures.3 Very little is known about the genetic factors 
predisposing patients to mucosal or disseminated candida infections.
Recognition of C. albicans by the innate host defense system is mediated by pat-
tern-recognition receptors from the toll-like–receptor (TLR) and lectinlike-receptor 
families.4 Mannans from the candida cell wall are recognized by the mannose re-
ceptor and TLR4,5 and TLR2 recognizes phospholipomannan6 and collaborates 
with the β-glucan receptor dectin-1 in the stimulation of cytokine production.7,8 
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Recognition of 1,3-linked β-glucans by dectin-1 
has been shown to be one of the main fungal-
recognition pathways, and mice deficient in dec-
tin-1 have an increased susceptibility to C. albicans9 
and Pneumocystis carinii.10 Dectin-1 amplifies TLR2- 
and TLR4-induced cytokine production in both 
murine and human cells, resulting in the produc-
tion of cytokines such as tumor necrosis factor,11 
but also induces signals, independently of the 
TLRs, for the production of interleukin-17, in-
terleukin-6, and interleukin-10 through a path-
way dependent on spleen tyrosine kinase.12
Me thods
Index Family and Other Subjects
To identify functional defects in the immune re-
sponse to C. albicans, we designed a functional 
screening assay of mononuclear cells isolated from 
patients with recurrent vulvovaginal candidiasis or 
oral or esophageal candidiasis. Cells were stimu-
lated with heat-killed C. albicans, and cytokine pro-
duction after 24 hours was assessed during screen-
ing. An immunologic and genetic analysis was 
performed on mononuclear cells obtained from a 
patient who had defective cytokine production, on 
stimulation with C. albicans or β-glucan, and from 
four family members. The study protocol was ap-
proved by the ethics committee of Nijmegen–Arn-
hem, the Netherlands. Written informed consent 
was obtained from all family members studied.
In addition, we studied DNA samples, previ-
ously collected to assess the prevalence of the 
Tyr238X mutations, from several populations in 
various geographic locations. These samples were 
obtained from the country of origin, with the ex-
ception of the Chinese Han cohort, for which 
samples were from the Corriell Institute (catalog 
number, HD1000CHI). For all populations, sub-
jects had provided written informed consent, and 
study approval was obtained from local ethics 
committees.
For haplotype analyses, we used genomewide 
data on single-nucleotide polymorphisms (SNPs) 
from 1422 whites from the 1958 United Kingdom 
birth cohort13 and from 171 Maasai from Kinyawa, 
Kenya.14 Genotype data for the Maasai population 
were downloaded from the International HapMap 
Project Web site (www.hapmap.org) and for the 
white population were obtained with the use of 
HumanHap300 BeadChips (Illumina). A region of 
20 kb around the SNP rs16910526 was extracted 
from all samples in both genomewide SNP data 
sets. We used the Beagle software program to 
determine the haplotypes from genotypes of all 
subjects.15
Genetic Analysis
A detailed description of the methods used to se-
quence the dectin-1 gene is presented in the Sup-
plementary Appendix (available with the full text 
of this article at NEJM.org). Network analysis was 
performed with the Network program, version 
4.5.0.0 (www.fluxus-engineering.com), which uses 
the median-joining method.16 The ancient haplo-
type was determined with the use of the dbSNP 
database (www.ncbi.nlm.nih.gov/projects/SNP/). 
Various analyses were conducted, with weighting 
applied separately for synonymous changes, non-
synonymous changes, transitions, and transver-
sions.
Modeling of Dectin-1 Structure
The crystal structure of mouse dectin (Protein Data 
Bank code 2cl8) was used as a template to build 
a homology model of the extracellular domain of 
human dectin-1. Modeling of the extracellular 
domain was preformed on the “WHAT IF” server 
(http.//swift.cmbi.ru.nl). Energy minimization and 
analysis were performed, to obtain the most reli-
able model of protein folding, with the YASARA 
program (www.yasara.org/).17
Fluorescence-Activated Cell Sorting
Human peripheral-blood mononuclear cells 
(PBMCs) were obtained from the three family 
members who were homozygous for a dectin-1 
mutation, the two family members who were 
heterozygous for a dectin-1 mutation, and five 
persons who were homozygous for the wild-type 
dectin-1 allele. The cells were incubated with mu-
rine anti–dectin-1 monoclonal antibody GE2 (5 μg 
per milliliter)18 or isotype-control antibody, fol-
lowed by allophycocyanin-conjugated goat anti-
mouse antibody (Pharmingen). Dectin-1 expres-
sion was determined by means of flow cytometry 
with the use of a fluorescence-activated cell sorter 
(FACSCalibur, BD Biosciences). Dectin-1 expression 
was assessed in cells from a mouse embryonic 
fibroblast cell line (NIH3T3) after transfection, 
with the use of an antihemagglutinin antibody 
(Covance), an IgG1 isotype-control antibody, and 
an antimouse antibody covalently labeled with 
R-phycoerythrin (Jackson ImmunoResearch).
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Candida Binding, Phagocytosis, and Fungal-
Killing Assays
Binding of PBMCs to C. albicans yeast cells was mea-
sured by means of flow cytometry.19 The phago-
cytosis and fungal-killing assays for C. albicans were 
performed as previously described.20
Cytokine Measurements
PBMCs12 (5×105) were incubated with 100 μl of 
β-glucan (10 μg per milliliter) and C. albicans that 
was live or had been heat-killed (through heating 
for 30 minutes at 56°C) at a concentration of 
1×106 yeast cells per milliliter. For interleukin-17 
stimulation assays, PBMCs were stimulated for 
5 days in RPMI medium supplemented with 10% 
pooled human serum. After 4 hours, 24 hours, or 
5 days of incubation at 37°C, supernatants were 
collected and stored at −70°C until enzyme-linked 
immunosorbent assay with the PeliKine-Tool set 
of  reagents (Sanquin).
Cloning and Transfection Studies
The human dectin-1 isoforms were amplified, by 
means of a polymerase-chain-reaction (PCR) as-
say, from complementary DNA isolated from sam-
ples of peripheral-blood leukocytes obtained from 
the patients. The two primers used were 5′-AAA-
GGATCCAGGGGCTCTCAAGAACAATG-3′ and 
5′-AA A CTCGAGTCTTCCACCCTTCCCCTTAC-3′. 
The PCR products were purified with the use of 
the QIAquick PCR purification kit (Qiagen), cloned 
into the pCR4-TOPO3.1 vector (Invitrogen), and 
sequenced. The wild-type and mutant dectin-1 
were cloned with the use of reverse primers — 
5′-CCCTTCCTCGAGCATTGAAAACTTC-3′ and 
5′-AA A TCTCGAGTGAGGGCAGACTAC-3′, respec-
tively — allowing for the in-frame cloning of a 
hem agglutinin tag, which does not affect β-glucan 
binding.7 The products were subcloned into the 
retroviral vector pFB-Neo (Stratagene) and trans-
fected into ecotropic packaging cells (Phoenix) with 
the use of FuGENE transfection reagent (Roche 
Molecular Biochemicals). After 48 hours, retrovi-
ral supernatants were harvested and used to trans-
duce NIH3T3 cells in the presence of Polybrene 
(Sigma), at a concentration of 5 μg per milliliter. 
A binding assay for zymosan was also performed, 
as previously described.21
R esult s
Patients and Pedigree
During the first phase of the screening, we iden-
tified a patient (the index patient) who had recur-
rent vulvovaginal candidiasis and had cells that 
were hyporesponsive to C. albicans stimulation, de-
fined as cytokine production that was 15% or less 
of that stimulated by C. albicans in cells from 
healthy volunteers. The lack of cytokine produc-
tion was pinpointed to an impaired response to 
β-glucan, indicating a potential defect in dec-
tin-1 recognition.
To test this hypothesis, we sequenced the dec-
tin-1 gene in the patient. All six exons of dectin-1 
gene, and the nearby intronic regions, were se-
quenced (see Table 1 in the Supplementary Appen-
dix). We identified a homozygous SNP in exon 
6 that caused a change of amino acid 238 from 
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Figure 1. Dectin-1 Mutation in a Family with Mucocuta-
neous Fungal Infections.
Panel A shows the structure of the dectin­1 gene and 
the location of an early­stop­codon mutation consist­
ing of  homozygous single­nucleotide polymorphism 
(rs16910526, exon 6, chromosome 12; location, 
10162354 bp). The mutation (A→C) causes a change of 
amino acid 238 from tyrosine to a stop codon (Tyr238X), 
leading to the loss of th  last nin  amino acids of the 
carbohydrate­recognition domain (CRD). Cyto denotes 
the cytoplasmic tail and TM the transmembrane re­
gion. Panel B shows the genetic pedigree of the index 
family with dectin­1 deficiency. Circles indicate female 
patients; the square indicates the father. Solid symbols 
denote homozygosity for the mutation (X/X, seen in  
all three daughters), and half­solid symbols denote 
heterozygosity (X/Tyr, seen in the parents).
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tyrosine to a stop codon (Tyr238X), leading to the 
loss of the last nine amino acids of the carbohy-
drate-recognition domain (Fig. 1A). Additional 
clinical questioning revealed that one of the pa-
tient’s two sisters also had recurrent vulvovaginal 
candidiasis and both sisters had onychomycosis. 
The mother of the patient also had chronic ony-
chomycosis, whereas the father had had only tran-
sient onychomycosis, with a relatively late age at 
onset and a complete recovery. The nucleotide se-
quence of wild-type dectin-1 in one healthy vol-
unteer and the nucleotide change (A→C) in exon 
6 in two persons who were heterozygous or ho-
mozygous for the stop mutation are shown in 
Figure S3A in the Supplementary Appendix.
The clinical characteristics of the patients are 
presented in Table 1. Microbiologic assessment of 
the nails of the three patients who were homozy-
gous for the dectin-1 mutation revealed growth of 
Trichophyton rubrum. The patients had no known 
predisposing factors, such as diabetes mellitus or 
infection with the human immunodeficiency vi-
rus. Genetic analysis revealed that both sisters of 
the patient were homozygous for the Tyr238X mu-
tation, whereas the parents were heterozygous 
(Fig. 1B). The family members were white persons 
of Dutch ancestry, according to self-report, and the 
parents were not known to be related. Investiga-
tion of the human dectin-1 protein structure con-
taining the early stop codon (Fig. S3B in the Sup-
plementary Appendix) revealed that a cysteine 
disulfide bridge between the helix and the de-
leted strand was absent, a finding likely to have 
important functional consequences.
Immunologic Defects
In the patients who had the early-stop-codon mu-
tation, both monocytes (Fig. 2A) and macrophag-
es (not shown) had significant defects in the pro-
duction of interleukin-6 after stimulation with 
β-glucan for 4 hours (P = 0.04 for monocytes). 
Similar defects were apparent after stimulation 
of cells with either heat-killed or live C. albicans 
yeast (Fig. S1A in the Supplementary Appendix). 
The cytokine response was also defective after 24 
hours of stimulation with heat-killed C. albicans 
hyphae (with a 25% reduction of tumor-necrosis-
factor production and a 34% reduction of inter-
leukin-6 release). In addition, cells from dectin-
1–deficient patients had a marked reduction in 
interleukin-17 production as compared with cells 
from persons with the dectin-1 wild-type allele 
(Fig. S4A in the Supplementary Appendix). Hetero-
zygotes had intermediate production of proin-
flammatory cytokines on stimulation with C. al-
bicans or β-glucan. In contrast, the response of the 
patients’ cells to TLR stimuli, such as lipopoly-
saccharide or lipopeptides, was normal (Fig. S1B 
in the Supplementary Appendix). In addition, the 
amplification effect of the interaction between 
β-glucan and dectin-1 on TLR2 stimulation of 
cytokines7 was absent in persons who were ho-
mozygous for the mutation (Fig. S1C in the Sup-
plementary Appendix).
To demonstrate that the defect in β-glucan rec-
ognition in the patients was indeed due to the 
truncated dectin-1 variant, we constructed vectors 
for both wild-type and mutated isoforms A and 
B of dectin-1 and transfected them into NIH3T3 
cells. These experiments revealed that neither mu-
tated isoform A nor mutated isoform B could me-
diate β-glucan binding, in contrast to the wild-
type receptors (Fig. S4B in the Supplementary 
Appendix). Moreover, although the wild-type dec-
tin-1 isoforms A and B were normally expressed, 
the mutated isoforms were associated with sig-
Table 1. Clinical Characteristics of a Family of Patients with the Tyr238X Dectin-1 Mutation and with Mucocutaneous Fungal Infection, 
Onychomycosis, or Both.
Characteristic
Index Patient 
(Female) Sister Sister Mother Father
Dectin­1 nucleotide genotype* X/X X/X X/X X/Tyr X/Tyr
Age (yr) 25 27 23 53 58
Age at onset of symptoms (yr) 10 10 12 40 55
Fingers and toes affected All fingers and 4 
toes, chronically
All fingers and toes, 
chronically
3 Fingers and 5 
toes, transiently
All fingers and toes, 
chronically
4 Toes partially affect­
ed, with complete 
recovery
Recurrent vulvovaginal  
candidiasis
Yes No Yes No Not applicable
* X denotes the presence of a stop codon, rather than tyrosine (Tyr), at amino acid 238.
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nificantly lower expression on the cell surface of 
the transfected cells (Fig. S4C in the Supplemen-
tary Appendix).
The in vitro data were corroborated in freshly 
isolated cells from the patients bearing the stop-
codon mutation. Messenger RNA production by 
cells with the dectin-1 isoforms was similar in 
persons who were homozygous for the wild-type 
allele and the patients who were homozygous for 
the stop mutation (Fig. S4D in the Supplementary 
Appendix). In contrast, monocytes and neutrophils 
from the patients who were homozygous for the 
stop-codon polymorphism lacked cell-membrane 
expression of dectin-1 (Fig. S4E in the Supplemen-
tary Appendix). Heterozygotes had intermediate 
expression of dectin-1.
The binding of heat-killed fluorescence-labeled 
C. albicans, which has high levels of β-glucan,22 to 
monocytes was significantly lower in the patients 
who were homozygous for the mutation than in 
healthy controls (Fig. 2B). However, phagocytosis 
of live C. albicans was normal in both monocytes 
and neutrophils from the patients who were ho-
mozygous for the stop codon (Fig. S2 in the Sup-
plementary Appendix), showing the importance of 
alternative receptors for phagocytosis of live yeasts 
(other lectinlike receptors and TLRs).4 Mono-
cytes and neutrophils from the patients who were 
homozygous for the mutation were as effective at 
killing C. albicans as were cells from normal per-
sons (Fig. S2 in the Supplementary Appendix).
Frequency of the Mutation in Populations
To determine whether the dectin-1 stop mutation 
was occurring in a phylogenetically conserved site, 
we compared the amino acid sequence of dectin-1 
among several mammals (Fig. S5A in the Supple-
mentary Appendix). This investigation revealed that 
the mutation lies in an evolutionarily conserved 
region within the mammalian lineage. We then 
investigated the prevalence of the mutation in vari-
ous human populations, and we genotyped per-
sons from four cohorts of healthy persons of vari-
ous ethnic groups, each representing populations 
from the major continents: 138 whites of Dutch 
ancestry (Europe), 99 people from Tanzania (Af-
rica), 100 Han Chinese (Asia), and 105 Trio Indians 
(Native Americans) from Surinam (South America). 
Dectin-1 was sequenced completely in the Dutch 
population, with Tyr238X being the only nonsyn-
onymous mutation identified. The Dutch popu-
lation had an allele frequency of 0.069, and the 
Tanzanian population, 0.035; all persons with 
the mutation were heterozygotes. The mutation 
was absent in the populations from China and 
Surinam. This variant has been recorded in the 
dbSNP database, as rs16910526.
A Human Genome Diversity Project selection 
browser was used to obtain further information 
about the frequency and world distribution of the 
SNP; this analysis confirmed our findings (Fig. 3). 
We analyzed haplotype diversity within a white 
population and a black population by studying 
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Figure 2. Functional Defects Resulting from Dectin-1 
Mutation.
Panel A shows interleukin­6 production in monocytes 
isolated after stimulation for 4 hours with β­glucan — 
for five healthy subjects with wild­type dectin­1 (with 
data pooled), the two patients who were heterozygous 
for the dectin­1 mutation, and the three patients who 
were homozygous for the mutation. Panel B shows the 
mean binding of nonopsonized fluorescent heat­killed 
Candida albicans to monocytes isolated from healthy 
subjects with wild­type dectin­1 and from the patients 
who were homozygous for the mutation. In both pan­
els, T bars indicate standard deviations.
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genomewide SNP data sets for samples obtained 
from 1422 whites from the U.K. 1958 birth co-
hort13 and 171 African Maasai from Kinyawa, Ken-
ya (from HapMap Phase III).14 Allele frequencies 
of the polymorphism within both populations did 
not differ significantly from those reported pre-
viously (whites, 0.078, and blacks, 0.023, as mea-
sured in our populations).13 Minimal mutation-
network analysis revealed that, among the 23 
haplotypes found in both populations, only 2 con-
tain the stop mutation (Fig. SB in the Supplemen-
tary Appendix). Both haplotypes are present in 
both the European and African populations, and 
therefore are not population specific. In addition, 
the haplotypes are located near the ancient hap-
lotype in the network, indicating that they are 
closely related to the ancient haplotype (Fig. S5C 
in the Supplementary Appendix).
Discussion
Defective surface expression of dectin-1 due to the 
Tyr238X polymorphism results in lack of β-glucan 
recognition and an impaired cytokine response 
by monocytes and macrophages but normal kill-
ing of C. albicans by neutrophils. These data show 
the important role of β-glucan–dectin-1 pathways 
for normal activation of the cytokine response,23 
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Figure 3. Polymorphisms and Haplotypes of the Dectin-1 Stop Mutation Worldwide.
The frequency of the dectin­1 polymorphism rs16910526 is shown for various populations of the world. The ancestral allele A leads to a 
functional dectin­1 receptor, whereas the derived allele C leads to an early­stop­codon mutation and nonfunctional dectin­1 receptor. 
The derived allele is observed only in populations from Africa and western Eurasia. The highest prevalence of the mutation (nearly 40%) 
is found in the San population in South Africa.
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but also show the redundant nature of dectin-1 in 
the phagocytosis and killing of Candida albicans. 
The normal function of neutrophils in persons in 
whom dectin-1 function is absent provides pro-
tection against invasive fungal infection. In con-
trast, the defective function of monocytes and 
macrophages with regard to cytokine release in 
the patients who were homozygous for the 
Tyr238X dectin-1 mutation is the most likely 
cause of the clinical phenotype characterized by 
mucocutaneous fungal infections.
Dysregulation of cytokine profiles is typically 
seen in patients with mucocutaneous fungal in-
fections such as recurrent vulvovaginal candidi-
asis.24 Dectin-1 is expressed on epithelial cells, and 
proinflammatory cytokines have been reported to 
be secreted by vaginal epithelial cells25 and to in-
crease the natural antifungal activity of these 
cells.26 It is therefore conceivable that dectin-1 
function on epithelial cells would also be defective 
in our patients. Our data showing that a complete 
deficiency of dectin-1 is accompanied by mucosal 
fungal infections are in line with a recent study 
showing the susceptibility of dectin-1–knockout 
mice to mucosal candidiasis.27
Dectin-1 is also important for the development 
of the responses of type 17 helper T cells,28 and 
interleukin-17 production in our patients with de-
fective dectin-1, as compared with healthy subjects, 
was reduced by 50% to 80% (Fig. S4A in the Sup-
plementary Appendix). A clinical syndrome that 
closely resembles the syndrome in our family, with 
regard to fungal complications, is the hyper-IgE 
syndrome. Patients with the hyper-IgE syndrome 
have a defect in interleukin-17 production in re-
sponse to infections with Staphylococcus aureus (cu-
taneous and pulmonary infection) and C. albicans 
(onychomycosis and mucosal infection).29,30 Our 
family had an isolated interleukin-17 defect in re-
sponse to C. albicans stimulation, and it is tempt-
ing to speculate that this is the cause of the 
clinical picture of fungal infections in the pa-
tients. Our findings are strengthened by the 
description in this issue of the Journal of a fam-
ily with a mutation of CARD9, the adaptor mol-
ecule for dectin-1, who presented with a pheno-
type practically identical to that of our family.31
Finally, the finding of this dectin-1 mutation in 
persons from both Europe and Africa leads to 
additional hypotheses. First, the identification of 
this polymorphism in all African populations as-
sessed (including the San population) suggests 
that this is an ancient mutation that most likely 
emerged more than 60,000 years ago, before the 
split of the modern human populations in the late 
Paleolithic.32 This hypothesis is supported by the 
finding that the location of the haplotypes con-
taining the Tyr238X mutation was close to the 
ancient haplotype. Second, the relatively high 
prevalence of the polymorphism in these popu-
lations may represent an important genetic sus-
ceptibility factor for mucosal fungal infection.
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